Bonus BioGroup Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BBIXF research report →
Companywww.bonusbiogroup.com
Bonus BioGroup Ltd. , a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. It develops tissue-regenerating bone grafts from cells derived from the patient's own cells for the treatment of skeletal disorders, such as bone trauma and arthritis.
- CEO
- Shai Meretzki
- IPO
- 2019
- Employees
- 49
- HQ
- Haifa, IL
Price Chart
Valuation
- Market Cap
- $151.83M
- P/E
- -14.97
- P/S
- 0.00
- P/B
- -165.63
- EV/EBITDA
- -29.75
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -1541.00%
- ROIC
- -225.90%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-24,372,879 · 12.41%
- EPS
- $-0.04 · -53.36%
- Op Income
- $-22,527,744
- FCF YoY
- 31.51%
Performance & Tape
- 52W High
- $0.15
- 52W Low
- $0.00
- 50D MA
- $0.09
- 200D MA
- $0.08
- Beta
- 0.86
- Avg Volume
- 541
Get TickerSpark's AI analysis on BBIXF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BBIXF Coverage
We haven't published any research on BBIXF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BBIXF Report →